脑转移管理的演变:一个图书法分析分析
Ikram A Burney1,2, Aya H Aal Hamad3, Syed F A Hashmi1
1Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat 123, Oman.
Cancers
|December 9, 2023
概括
脑转移的管理已经进化,超越全脑辐射疗法 (WBRT) 进行向治疗. 现代方法包括放射性外科手术,新型药物如氨酸激酶抑制剂 (TKI) 和免疫检查点抑制剂 (ICI).
科学领域:
- 神经瘤学神经瘤学
- 医学瘤学 医学瘤学
- 辐射瘤学 辐射瘤学
背景情况:
- 大脑转移代表了癌症治疗中的重大挑战.
- 了解它们管理的演变对于改善患者的治疗结果至关重要.
- 需要对随时间推移的治疗趋势进行全面分析.
研究的目的:
- 系统地审查和分析大脑转移的演变管理策略.
- 在过去的45年里,确定治疗范式的关键趋势和转变.
- 为了突出治疗领域最近的进展.
主要方法:
- 关于大脑转移管理临床研究的系统性文献综述.
- 关键词:"大脑转移"",中枢神经系统转移"",第三期"",随机对照试验" (RCT).
- 数据库搜索:SCOPUS; 时间:1977-2022; 不包括:成像,生活质量,认知障碍,原发性脑瘤.
主要成果:
- 从1986年最初的检索中确定了724件相关的物品.
- 在过去的十年中,出版率显著增加.
- 最近的趋势 (2017-2022) 显示了从WBRT转向SRS/SRT,新型药物 (TKI,ICI) 和分子向疗法.
结论:
- 大脑转移的管理已经显著发展,转向更少的毒性和更有针对性的疗法.
- 进步包括降低毒性辐射技术和整合系统疗法,如TKI和ICI.
- 未来的方向集中在无症状,低体积转移的精密医学上.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


